Resultats de la cerca - Sally Arai

Refinar resultats
  1. 1
    Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment

    Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment per Sally Arai, Jeffrey Margolis, Marianna Zahurak, Viki Anders, Georgia B. Vogelsang

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Crypt loss is a marker of clinical severity of acute gastrointestinal graft‐versus‐host disease

    Crypt loss is a marker of clinical severity of acute gastrointestinal graft‐versus‐host disease per Joshua Melson, Shriram Jakate, Henry C. Fung, Sally Arai, Ali Keshavarzian

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis

    Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis per Gregory P. Kaufman, Stanley L. Schrier, Richard A. Lafayette, Sally Arai, Ronald Witteles, Michaela Liedtke

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement

    Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement per Shira Dinner, Wesley Witteles, Anosheh Afghahi, Ronald Witteles, Sally Arai, Richard A. Lafayette, S. Schrier, Michaela Liedtke

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/<i>neu</i>–Positive Breast Cancer

    A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/<i>neu</i>–Positive Breast Cancer per Allison W. Kurian, Rebecca Newton Thompson, Allison F. Gaw, Sally Arai, Rafael Ortiz, Alan M. Garber

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review

    Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review per Yazan Migdady, Asiri Ediriwickrema, Ryan P. Jackson, Wendy Kadi, Ridhi Gupta, Francisco Socola, Sally Arai, Beth A. Martin

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era

    Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era per Margot K. Davis, Parag Kale, Michaela Liedtke, S. Schrier, Sally Arai, Matthew T. Wheeler, Richard A. Lafayette, Terra R. Coakley, Ronald Witteles

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Organ responses with daratumumab therapy in previously treated AL amyloidosis

    Organ responses with daratumumab therapy in previously treated AL amyloidosis per Alfred Chung, Gregory P. Kaufman, Surbhi Sidana, Erik Eckhert, Stanley L. Schrier, Richard A. Lafayette, Sally Arai, Ronald Witteles, Michaela Liedtke

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion

    Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion per Görgün Akpek, John K. Boitnott, Linda A. Lee, Jason P. Hallick, Michael Torbenson, David A. Jacobsohn, Sally Arai, Viki Anders, Georgia B. Vogelsang

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein

    The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein per Ari Melnick, Jennifer J. Westendorf, Adam Polinger, Graeme W. Carlile, Sally Arai, Helen J. Ball, Bart Lutterbach, Scott W. Hiebert, Jonathan D. Licht

    Publicat 2000
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    In-Depth Mutational Analysis of the Promyelocytic Leukemia Zinc Finger BTB/POZ Domain Reveals Motifs and Residues Required for Biological and Transcriptional Functions

    In-Depth Mutational Analysis of the Promyelocytic Leukemia Zinc Finger BTB/POZ Domain Reveals Motifs and Residues Required for Biological and Transcriptional Functions per Ari Melnick, Kami Ahmad, Sally Arai, Adam Polinger, Helen J. Ball, Katherine L. B. Borden, Graeme W. Carlile, Gilbert G. Privé, Jonathan D. Licht

    Publicat 2000
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation

    Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation per Christopher D. Barrett, Kevin Alexander, Hongyu Zhao, François Haddad, Paul Cheng, Ronglih Liao, Matthew T. Wheeler, Michaela Liedtke, Stanley L. Schrier, Sally Arai, Dana Weisshaar, Ronald Witteles

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

    Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-... per Joseph Pidala, Georgia B. Vogelsang, Martin Petřek, X. Chai, B. Storer, Steven Z. Pavletic, Daniel J. Weisdorf, Madan Jagasia, Corey Cutler, Joycelynne Palmer, D. Jacobsohn, Sally Arai, S. J. Lee

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

    Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consort... per Joseph Pidala, Brenda F. Kurland, Xiaoyu Chai, Navneet S. Majhail, Daniel J. Weisdorf, Steven Z. Pavletic, Corey Cutler, David A. Jacobsohn, Jeanne Palmer, Sally Arai, Madan Jagasia, Stephanie J. Lee

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

    An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease per Paul J. Martin, Barry E. Storer, Yoshihiro Inamoto, Mary E.D. Flowers, Paul A. Carpenter, Joseph Pidala, Jeanne Palmer, Mukta Arora, Madan Jagasia, Sally Arai, Corey Cutler, Stephanie J. Lee

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia

    Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia per Michael S. Khodadoust, Bin Luo, Bruno C. Medeiros, Ryan C. Johnson, Mark D. Ewalt, A S Schalkwyk, Charles D. Bangs, Athena M. Cherry, Sally Arai, Daniel A. Arber, James L. Zehnder, Jason Gotlib

    Publicat 2015
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  17. 17
    Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

    Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation per Ginna G. Laport, Kevin Sheehan, Jeanette Baker, Randall Armstrong, Ruby M. Wong, Robert Lowsky, Laura Johnston, Judith A. Shizuru, David B. Miklos, Sally Arai, Jonathan Benjamin, Wen-Kai Weng, Robert S. Negrin

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

    High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation per Navneet S. Majhail, Mary E.D. Flowers, Kirsten K. Ness, Madan Jagasia, Paul A. Carpenter, Mukta Arora, Sally Arai, Laura Johnston, Paul J. Martin, K. Scott Baker, S J Lee, Linda J. Burns

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Association of Foxp3 regulatory gene expression with graft-versus-host disease

    Association of Foxp3 regulatory gene expression with graft-versus-host disease per Yuji Miura, Christopher J. Thoburn, Emilie C. Bright, Michele Phelps, Tahiro Shin, Elizabeth C. Matsui, William Matsui, Sally Arai, Ephraim J. Fuchs, Georgia B. Vogelsang, Richard J. Jones, Allan D. Hess

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Donor-derived MDS/AML in families with germline GATA2 mutation

    Donor-derived MDS/AML in families with germline GATA2 mutation per Pallavi Galera, Amy P. Hsu, Weixin Wang, Stephenie Droll, Rui Chen, Jason R. Schwartz, Jeffery M. Klco, Sally Arai, Luke Maese, Christa S. Zerbe, Mark Parta, Neal S. Young, Steven M. Holland, Dennis D. Hickstein, Katherine R. Calvo

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:

Eines de cerca: